Simble Point收购，Pear Treeutics完成SPAC合并；合并后的公司将于周一开始交易

04:32 PM EST, 12/03/2021 (MT Newswires) -- Thimble Point Acquisition Corp (THMA) has completed its merger with privately held Pear Therapeutics, which will begin trading Monday under the PEAR ticker symbol.

Thimble Point shareholders signed off on the deal earlier this week, joining investors of the prescription digital therapeutics company who had previously approved the business combination with the blank-check company.

The transaction generated about $175 million in gross proceeds, according to a statement released late Friday.

Pear Therapeutics late last month received a breakthrough device designation from the US Food and Drug Administration for its reSET-A PDT product candidate designed for the treatment of alcohol use disorder.